# Study of Patient Preference for Oral or Intravenous Vinorelbine in the Treatment of Advanced NSCLC

> **NCT01848613** · PHASE4 · COMPLETED · sponsor: **Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS** · enrollment: 120 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer Metastatic

## Interventions

- **DRUG:** Vinorelbine

## Key facts

- **NCT ID:** NCT01848613
- **Lead sponsor:** Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2016-10
- **Final completion:** 2018-05
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2018-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01848613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01848613, "Study of Patient Preference for Oral or Intravenous Vinorelbine in the Treatment of Advanced NSCLC". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01848613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*